In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 752 for your search:
Drug:  filgrastim
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 0 to 18
Sponsor: NCI
Protocol IDs: CCG-3891

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: E-1193, NCCTG-923252, SWOG-9332, E-10292, E1193

4.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AHOD0121, CDR0000330135, COG-AHOD0121, NCT00070187

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 55 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000066016, P30CA016059, MCV-CCHR-9504-2X, DUMC-75951, NCI-G98-1388, NCT00003187

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9313, CLB-9394, E-S9313, NCCTG-933051, INT-0137

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no greater than 60
Sponsor: NCI
Protocol IDs: NU-93B1, NCI-T93-0058D, T93-0058

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-26

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9342, CALGB-9342

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no greater than 65
Sponsor: NCI
Protocol IDs: FHCRC-772.01, NCI-H94-0370

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: POG-9331, CCG-9932, INT-0140

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: CLB-9344, E-C9344, NCCTG-943051, SWOG-9410, INT-0148

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 12 and over
Sponsor: NCI
Protocol IDs: MSKCC-94076, CLB-99812, E-3894, SWOG-9442, NCI-T94-0086D, NCT00002596, T94-0086

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9406, POG-ALINC-16/HR

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21 at diagnosis
Sponsor: NCI
Protocol IDs: CCG-5942

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 22
Sponsor: NCI, Other
Protocol IDs: CDR0000063955, POG-9315, NCT00002618

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI
Protocol IDs: POG-9354, CCG-7942, INT-0154

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9249

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-163, GOG-0163

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: E-2493, E2493

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 55
Sponsor: NCI
Protocol IDs: MDA-DM-94106, NCI-G96-1008

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI, Other
Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: DM95-047, P30CA016672, MDA-DM-95047, NCI-G96-1014, CDR0000065048, NCT00002836

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065146, MRC-LEUK-CML-2000, ECOG-E7995, MRC-LEUK-CML-IV, MRC-LEUK-CML-IVa, EU-96029, E7995, NCT00002868
1     
New Search